Astrana Health Business Summary

Astrana Health, Inc. (ASTH) operates as a physician-centric, technology-powered healthcare management company specializing in value-based care (VBC) delivery. The company generates revenue primarily through capitation payments, where it receives a fixed monthly fee per member to manage total cost of care, alongside risk pool settlements, management fees from its Management Services Organization (MSO), and traditional fee-for-service clinical income. Its operations are organized into three primary segments: Care Partners, which manages provider networks and risk-bearing contracts; Care Delivery, which provides direct patient care through its primary, multi-specialty, and post-acute clinics; and Care Enablement, which offers a proprietary end-to-end population health technology platform. Astrana differentiates itself from direct competitors like Agilon Health, Privia Health, and CareMax by maintaining a highly integrated, "full-risk" ecosystem that combines clinical delivery with advanced AI-driven data analytics to optimize patient outcomes and reduce medical spend. The leadership team is anchored by Co-Founders Dr. Kenneth Sim, who serves as Executive Chairman, and Dr. Thomas Lam, the company’s Vice Chairman. Brandon Sim leads the organization as President and Chief Executive Officer, bringing a background in quantitative research from Citadel Securities and technology leadership as the former CTO of Theratech. The executive suite is further supported by Chan Basho (CFO & COO) and Dr. Dinesh Kumar (Chief Medical Officer). Astrana’s governance is bolstered by a high-profile Board of Directors, including former California State Treasurer John Chiang and Marvell Technology co-founder Weili Dai. The company maintains a strong institutional investor base, with significant positions held by BlackRock, Vanguard, and State Street, reflecting its established position as a scaled, profitable player in the transition toward risk-based healthcare reimbursement.